title: Superior protection elicited by live-attenuated vaccines in the murine model of paratuberculosis.
abstract: Mycobacterium avium subspecies paratuberculosis (M. paratuberculosis) causes Johne's disease, a chronic enteric infection in ruminants with severe economic impact on the dairy industry in the USA and worldwide. Currently, available vaccines have limited protective efficacy against disease progression and does not prevent spread of the infection among animals. Because of their ability to elicit wide-spectrum immune responses, we adopted a live-attenuated vaccine approach based on a sigH knock-out strain of M. paratuberculosis (ΔsigH). Earlier analysis of the ΔsigH mutant in mice indicated their inadequate ability to colonize host tissues, unlike the isogenic wild-type strain, validating the role of this sigma factor in M. paratuberculosis virulence. In the present study, we evaluated the performance of the ΔsigH mutant compared to inactivated vaccine constructs in a vaccine/challenge model of murine paratuberculosis. The presented analysis indicated that ΔsigH mutant with or without QuilA adjuvant is capable of eliciting strong immune responses (such as interferon gamma-γ, IFN-γ) suggesting their immunogenicity and ability to potentially initiate effective vaccine-induced immunity. Following a challenge with virulent strains of M. paratuberculosis, ΔsigH conferred protective immunity as indicated by the reduced bacterial burden accompanied with reduced lesions in main body organs (liver, spleen and intestine) usually infected with M. paratuberculosis. More importantly, our data indicated better ability of the ΔsigH vaccine to confer protection compared to the inactivated vaccine constructs even with the presence of oil-adjuvant. Overall, our approach provides a rational basis for using live-attenuated mutant strains to develop improved vaccines that elicit robust immunity against this chronic infection.
authors.affiliation: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA. Electronic address: pallab_ghosh@hms.harvard.edu.
authors.forename: Pallab
authors.initials: P
authors.lastname: Ghosh
authors.affiliation: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA; Pan Genome Systems, Madison, WI, USA.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Shippy
authors.affiliation: Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA; Pan Genome Systems, Madison, WI, USA. Electronic address: atalaat@wisc.edu.
authors.forename: Adel M
authors.initials: AM
authors.lastname: Talaat
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000825:Animal Structures / Q000473:pathology; D000818:Animals; D058491:Bacterial Load; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D004195:Disease Models, Animal; D005260:Female; D055786:Gene Knockout Techniques; D007371:Interferon-gamma / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008810:Mice, Inbred C57BL; D016927:Mycobacterium avium subsp. paratuberculosis / Q000235:genetics / Q000276:immunology*; D010283:Paratuberculosis / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D062605:Quillaja Saponins / Q000008:administration & dosage; D012808:Sigma Factor / Q000172:deficiency; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014774:Virulence; D037521:Virulence Factors / Q000172:deficiency
chemical_list: D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D062605:Quillaja Saponins; D012808:Sigma Factor; D014613:Vaccines, Attenuated; D037521:Virulence Factors; C046386:Quil A; D007371:Interferon-gamma
keywords: Adjuvant; Johne's disease; Live attenuated vaccine; Mycobacterium avium subsp. paratuberculosis; Sigma factor sigH